T. Rowe Price Investment Management
CLBT icon

T. Rowe Price Investment Management’s Cellebrite CLBT Stock Holding History

T. Rowe Price Investment Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.8M Sell
2,380,602
-934,790
-28% -$12.4M 0.02% 464
2026
Q1 		$45.7M Sell
3,315,392
-5,199,502
-61% -$78.4M 0.03% 369
2025
Q4 		$154M Sell
8,514,894
-1,530,087
-15% -$27.5M 0.1% 193
2025
Q3 		$186M Buy
10,044,981
+3,527,104
+54% +$55.4M 0.11% 186
2025
Q2 		$104M Buy
6,517,877
+3,381,546
+108% +$60.3M 0.07% 271
2025
Q1 		$60.9M Buy
+3,136,331
New +$66M 0.04% 362

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

T. Rowe Price Investment Management's CLBT Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Cellebrite (CLBT) stake by 28% in Q2 2026, selling an estimated $12.4M and leaving 2,380,602 shares worth $34.8M. The position accounts for 0.02% of the portfolio, ranked #464.

T. Rowe Price Investment Management first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $186M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • T. Rowe Price Investment Management held 2,380,602 shares of Cellebrite worth $34.8M as of Q2 2026.
  • T. Rowe Price Investment Management sold 934,790 Cellebrite shares in Q2 2026, an estimated $12.4M.
  • Cellebrite made up 0.02% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #464 holding.
  • T. Rowe Price Investment Management first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • T. Rowe Price Investment Management's Cellebrite position peaked at $186M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.